X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs PLETHICO PHARMA - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON PLETHICO PHARMA BIOCON /
PLETHICO PHARMA
 
P/E (TTM) x 41.0 -1.1 - View Chart
P/BV x 7.1 0.0 42,512.3% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 BIOCON    PLETHICO PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-18
PLETHICO PHARMA
Mar-14
BIOCON /
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,188395 300.8%   
Low Rs30531 974.4%   
Sales per share (Unadj.) Rs68.7604.4 11.4%  
Earnings per share (Unadj.) Rs7.632.5 23.3%  
Cash flow per share (Unadj.) Rs14.051.3 27.2%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs86.3473.6 18.2%  
Shares outstanding (eoy) m600.0034.08 1,760.6%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.90.4 3,080.8%   
Avg P/E ratio x98.96.6 1,506.6%  
P/CF ratio (eoy) x53.44.2 1,287.0%  
Price / Book Value ratio x8.60.5 1,921.2%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m447,9007,262 6,167.3%   
No. of employees `0006.1NA-   
Total wages/salary Rs m9,3111,596 583.4%   
Avg. sales/employee Rs Th6,705.8NM-  
Avg. wages/employee Rs Th1,514.2NM-  
Avg. net profit/employee Rs Th736.9NM-  
INCOME DATA
Net Sales Rs m41,23420,598 200.2%  
Other income Rs m2,062386 533.7%   
Total revenues Rs m43,29620,984 206.3%   
Gross profit Rs m8,2912,818 294.3%  
Depreciation Rs m3,851642 599.6%   
Interest Rs m6151,593 38.6%   
Profit before tax Rs m5,887969 607.8%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569-138 -1,133.8%   
Profit after tax Rs m4,5311,107 409.3%  
Gross profit margin %20.113.7 147.0%  
Effective tax rate %26.7-14.3 -186.5%   
Net profit margin %11.05.4 204.5%  
BALANCE SHEET DATA
Current assets Rs m41,48618,877 219.8%   
Current liabilities Rs m21,41311,896 180.0%   
Net working cap to sales %48.733.9 143.6%  
Current ratio x1.91.6 122.1%  
Inventory Days Days6436 178.0%  
Debtors Days Days94198 47.6%  
Net fixed assets Rs m50,6619,861 513.8%   
Share capital Rs m3,000341 880.5%   
"Free" reserves Rs m48,80812,331 395.8%   
Net worth Rs m51,80816,139 321.0%   
Long term debt Rs m17,8984,706 380.3%   
Total assets Rs m99,89733,146 301.4%  
Interest coverage x10.61.6 657.5%   
Debt to equity ratio x0.30.3 118.5%  
Sales to assets ratio x0.40.6 66.4%   
Return on assets %5.28.1 63.2%  
Return on equity %8.76.9 127.5%  
Return on capital %9.612.3 78.4%  
Exports to sales %021.4 0.0%   
Imports to sales %015.2 0.0%   
Exports (fob) Rs mNA4,402 0.0%   
Imports (cif) Rs mNA3,136 0.0%   
Fx inflow Rs m12,0584,402 273.9%   
Fx outflow Rs m7,3483,184 230.8%   
Net fx Rs m4,7101,219 386.5%   
CASH FLOW
From Operations Rs m6,6212,437 271.6%  
From Investments Rs m-6,840-6,265 109.2%  
From Financial Activity Rs m-2,3972,490 -96.3%  
Net Cashflow Rs m-2,612-1,337 195.3%  

Share Holding

Indian Promoters % 40.4 82.7 48.9%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 4.3 195.3%  
FIIs % 10.7 5.5 194.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 7.5 265.3%  
Shareholders   109,995 10,665 1,031.4%  
Pledged promoter(s) holding % 0.0 85.7 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   DR. REDDYS LAB  UNICHEM LAB  WYETH LTD  ELDER PHARMA  ALEMBIC LTD  

Compare BIOCON With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 19.8% YoY). Sales on the other hand came in at Rs 12 bn (up 25.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 18, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS